The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: A review

Canadian Journal of Anesthesia

Volumn 50, Issue 7, 2003, Pages 732-746

  Dubé, Laurent ^a   Granry, Jean Claude ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DECAMETHONIUM; DIAZEPAM; DIURETIC AGENT; FENTANYL; GENTAMICIN; HALOTHANE; INHALATION ANESTHETIC AGENT; INSULIN; KETAMINE; LOOP DIURETIC AGENT; MAGNESIUM; MAGNESIUM CHLORIDE; MAGNESIUM SULFATE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXALIPLATIN; PHENYTOIN; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SUXAMETHONIUM; TUBOCURARINE CHLORIDE;

ADRENERGIC SYSTEM; ANALGESIA; ANESTHESIOLOGY; ANESTHESIST; ASTHMA; BRADYCARDIA; CATECHOLAMINE RELEASE; DRUG INDICATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG USE; ECLAMPSIA; EMERGENCY MEDICINE; FLUSHING; HEADACHE; HEART ARRHYTHMIA; HEART INFARCTION; HEART SURGERY; HUMAN; HYPOMAGNESEMIA; INTENSIVE CARE; INTUBATION; LUNG EDEMA; MEDICAL SPECIALIST; MEDLINE; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; PHEOCHROMOCYTOMA; POSTOPERATIVE COMPLICATION; PREECLAMPSIA; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; SEIZURE; SKIN MANIFESTATION;

EID: 0142180198     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018719     Document Type: Review

References (115)

1. Delhumeau A, Granry JC, Monrigal J-P, Costerousse F. Therapeutic use of magnesium in anaesthesia and intensive care (French). Ann Fr Anesth Réanim 1995; 14: 406-16.
2. Sanders GT, Huijgen HJ, Sanders R. Magnesium in disease: a review with special emphasis on the serum ionized magnesium. Clin Chem Lab Med 1999; 37: 1011-33.
3. Saris NE L, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clinica Chimica Acta 2000; 294: 1-26.
4. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth 1999; 83: 302-20.
5. Dacey MJ. Hypomagnesemic disorders. Crit Care Clin 2001; 17: 155-73.
6. Kelepouris E, Agus ZS. Hypomagnesemia: renal magnesium handling. Semin Nephrol 1998; 18: 58-73.
7. Quamme GA. Renal magnesium handling: new insights in understanding old problems. Kidney Int 1997; 52: 1180-95.
8. De Rouffignac Q, Quamme G. Renal magnesium handling and its hormonal control. Physiol Rev 1994; 74: 305-22.
9. Zaloga GP, Chernow B. Divalent ions: calcium, magnesium, and phosphorus. In: Chernow B (Ed.). The Pharmacologic Approach to the Critically Ill Patient, 3rd ed. Baltimore: Williams and Wilkins Inc.; 1994: 777-804.
10. Swain R, Kaplan-Machlis B. Magnesium for the next millennium. South Med J 1999; 92: 1040-7.
11. Tramèr MR, Schneider J, Marti RA, Rifat K. Role of magnesium sulfate in postoperative analgesia. Anesthesiology 1996; 84: 340-7.
12. Ko SH, Lim HR, Kim DC, Han YJ, Choe H, Song HS. Magnesium sulfate does not reduce postoperative analgesic requirements. Anesthesiology 2001; 95: 640-6.
13. Koinig H, Wallner T, Marhofer P, Andel H, Hörauf K, Mayer N. Magnesium sulfate reduces intra- and postoperative analgesic requirements. Anesth Analg 1998; 87: 206-10.
14. Fanning WJ, Thomas CS Jr, Roach A, Tomicheck R, Alford WC, Stoney WS Jr. Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting. Ann Thorac Surg 1991; 52: 529-33.
15. Speziale G, Ruvolo G, Fattouch K, et al. Arrhythmia prophylaxis after coronary artery bypass grafting: regimens of magnesium sulfate administration. Thorac Cardiovasc Surg 2000; 48: 22-6.
16. Aglio LS, Stanford GG, Maddi R, Boyd JL III, Nussbaum S, Chernow B. Hypomagnesemia is common following cardiac surgery. J Cardiothorac Vasc Anesth 1991; 5: 201-8.
17. Zuccala G, Pahor M, Lattanzio F, et al. Detection of arrhythmogenic cellular magnesium depletion in hip surgery patients. Br J Anaesth 1997; 79: 776-81.
18. Reinhart RA. Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular system. Am Heart J 1991; 121: 1513-21.
19. Kafiluddi R, Kennedy RH, Seifen E. Effects of buffer magnesium on positive inotropic agents in guinea pig cardiac muscle. Eur J Pharmacol 1989; 165: 181-9.
20. Rasmussen HS, Videbaek R, Melchior T, Aurup P, Cintin C, Pedersen NT. Myocardial contractility and performance capacity after magnesium infusions in young healthy persons: a double-blind, placebo-controlled, cross-over study. Clin Cardiol 1988; 11: 541-5.
21. Altura BM, Altura BT. Influence of magnesium on drug-induced contractions and ion content of rabbit aorta. Am J Physiol 1971; 220: 938-44.
22. Altura BM, Turlapaty PDMV. Withdrawal of magnesium enhances coronary arterial spasms produced by vasoactive agents. Br J Pharmacol 1982; 77: 649-59
23. Goto K, Yasue H, Okumura K, et al. Magnesium deficiency detected by intravenous loading test in variant angina pectoris. Am J Cardiol 1990; 65: 709-12.
24. Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G. The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 2000; 118: 1690-5.
25. Akazawa S, Shimizu R, Nakaigawa Y, Ishii R, Ikeno S, Yamato R. Effects of magnesium sulphate on atrioventricular conduction times and surface electrocardiogram in dogs anaesthetized with sevoflurane. Br J Anaesth 1997; 78: 75-80.
26. Vigorito C, Giordano A, Ferraro P, et al. Hemodynamic effects of magnesium sulfate on the normal human heart. Am J Cardiol 1991; 67: 1435-7.
27. Delhumeau A, Granry JC, Cottineau C, Bukowski JG, Corbeau JJ, Moreau X. Comparative vascular effects of magnesium sulphate and nicardipine during cardiopulmonary bypass (French). Ann Fr Anesth Réanim 1995; 14: 149-53.
28. Krendel DA. Hypermagnesemia and neuromuscular transmission. Semin Neurol 1990; 10: 42-5.
29. Mordes JP, Wacker WE. Excess magnesium. Pharmacol Rev 1977; 29: 273-300.
30. Frakes MA, Richardson LE. Magnesium sulfate therapy in certain emergency conditions. Am J Emerg Med 1997; 15: 182-7.
31. Steer CM, Petrie RH. A comparison of magnesium sulfate and alcohol for the prevention of premature labor. Am J Obstet Gynecol 1977; 129: 1-4.
32. Terrone DA, Rinehart BK, Kimmel ES, May WL, Larmon JE, Morrison JC. A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis. Am J Obstet Gynecol 2000; 182: 1477-82.
33. Crowther C. Magnesium sulphate versus diazepam in the management of eclampsia: a randomized controlled trial. Br J Obstet Gynaecol 1990; 97: 110-7.
34. Morisaki H, Yamamoto S, Morita Y, Kotake Y, Ochiai R, Takeda J. Hypermagnesemia-induced cardiopulmonary arrest before induction of anesthesia for emergency cesarean section. J Clin Anesth 2000; 12: 224-6.
35. Walker JJ. Pre-eclampsia. Lancet 2000; 356: 1260-5.
36. The Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359: 187-90.
37. Arnold A, Tovey J, Mangat P, Penny W, Jacobs S. Magnesium deficiency in critically ill patients. Anaesthesia 1995; 50: 203-5.
38. Wong ET, Rude RK, Singer FR, Shaw ST Jr. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol 1983; 79: 348-52.
39. Rubeiz GJ, Thill-Baharozian M, Hardie D, Carlson RW. Association of hypomagnesemia and mortality in acutely ill medical patients. Crit Care Med 1993; 21: 203-9.
40. Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. JAMA 1990; 263: 3063-4.
41. Chernow B, Bamberger S, Stoiko M, et al. Hypomagnesemia in patients in postoperative intensive care. Chest 1989; 95: 391-7.
42. Ryzen E, Wagers PW, Singer FR, Rude RK. Magnesium deficiency in a medical ICU population. Crit Care Med 1985; 13: 19-21.
43. England MR, Gordon G, Salem M, Chernow B. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial. JAMA 1992; 268: 2395-402.
44. Whang R, Whang DD, Ryan MP. Refractory potassium repletion. A consequence of magnesium deficiency. Arch Intern Med 1992; 152: 40-5.
45. Fung MC, Weintraub M, Bowen DL. Hypermagnesemia. Elderly over-the-counter drug users at risk. Arch Fam Med 1995; 4: 718-23.
46. James MFM, Beer RE, Esser JD. Intravenous magnesium sulfate inhibits catecholamine release associated with tracheal intubation. Anesth Analg 1989; 68: 772-6.
47. Puri GD, Marudhachalam KS, Chari P, Suri RK The effect of magnesium sulphate on hemodynamics and its efficacy in attenuating the response to endotracheal intubation in patients with coronary artery disease. Anesth Analg 1998; 87: 808-11.
48. Yap LC, Ho RT, Jawan B, Lee JH. Effects of magnesium sulfate pretreatment on succinylcholine-facilitated tracheal intubation. Acta Anaesthesiol Sin 1994; 32: 45-50.
49. Ashton WB, James MFM, Janicki P, Uys PC. Attenuation of the pressor response to tracheal intubation by magnesium sulphate with and without alfentanil in hypertensive proteinuric patients undergoing caesarean section. Br J Anaesth 1991; 67: 741-7.
50. James MFM. Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: a review of 17 anaesthetics. Br J Anaesth 1989; 62: 616-23.
51. Drolet P, Girard M. The use of magnesium sulfate during surgery of pheochromocytoma: apropos of 2 cases (French). Can J Anaesth 1993; 40: 521-5.
52. Lim KS, Low TC, Ng BK, Rajasoorya C. A case report of the use of magnesium sulphate during anaesthesia in a patient who had adrenalectomy for phaeochromocytoma. Ann Acad Med Singapore 2000; 29: 518-20.
53. Pitt-Miller P, Primus E. Use of magnesium sulphate as adjunctive therapy for resection of phaeochromocytoma. West Indian Med J 2000; 49: 73-5.
54. James MFM, Huddle KRL, Owen AD, van der Veen BW. Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma in pregnancy. Can J Anaesth 1988; 35: 178-82.
55. Zaman AG, Alamgir F, Richens T, Williams R, Rothman MT, Mills PG. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart 1997; 77: 527-31.
56. Yeatman M, Caputo M, Narayan P, et al. Magnesium-supplemented warm blood cardioplegia in patients undergoing coronary artery revascularization. Ann Thorac Surg 2002; 73: 112-8.
57. Toraman F, Karabulut EH, Alhan HC, Dagdelen S, Tarcan S. Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2001; 72: 1256-61.
58. Nastou H, Sarros G, Nastos A, Sarrou V, Anastassopoulou J. Prophylactic effects of intravenous magnesium on hypertensive emergencies after cataract surgery. A new contribution to the pharmacological use of magnesium in anaesthesiology. Magnes Res 1995; 8: 271-6.
59. Bert AA, Reinert SE, Singh AK. A β-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2001; 15: 204-9.
60. Dorman BH, Sade RM, Burnette JS, et al. Magnesium supplementation in the prevention of arrhythmias in pediatric patients undergoing surgery for congenital heart defects. Am Heart J 2000; 139: 522-8.
61. Keren A, Tzivoni D. Torsades de pointes: prevention and therapy. Cardiovasc Drugs Ther 1991; 5: 509-14.
62. Moran JL, Gallagher J, Peake SL, Cunningham DN, Salagaras M, Leppard P. Parenteral magnesium sulphate versus amiodarone in the therapy of atrial tachyarrhythmias a prospective, randomized study. Crit Care Med 1995; 23: 1816-24.
63. Rudnicki M, Frolich A, Rasmussen WF, McNair P. The effect of magnesium on maternal blood pressure in pregnancy-induced hypertension. Acta Obstet Gynecol Scand 1991; 70: 445-50.
64. Rudnicki M, Frolich A, Pilsgaard K, et al. Comparison of magnesium and methyldopa for the control of blood pressure in pregnancies complicated with hypertension. Gynecol Obstet Invest 2000; 49: 231-5.
65. Vincent RD Jr, Chestnut DH, Sipes SL, Weiner CP, DeBruyn CS, Bleuer SA. Magnesium sulfate decreases maternal blood pressure but not uterine blood flow during epidural anesthesia in gravid ewes. Anesthesiology 1991; 74: 77-82.
66. Lu JF, Nightingale CH. Magnesium sulfate in eclampsia and pre-eclampsia. Clin Pharmacokinet 2000; 38: 305-14.
67. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia. Trial. Lancet 1995; 345: 1455-63.
68. Belfort MA, Moise KJ Jr. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 1992; 167: 661-6.
69. Coetzee EJ, Dommisse J, Anthony J. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol 1998; 105: 300-3.
70. Chen FP, Chang SD, Chu KK. Expectant management in severe preeclampsia: does magnesium sulphate prevent the development of eclampsia? Acta Obstet Gynecol Scand 1995; 74: 181-5.
71. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201-5.
72. Friedman SA, Lim KH, Baker CA, Repke JT. Phenytoin versus magnesium sulphate in preeclampsia: a pilot study. Am J Perinatol 1993; 10: 233-8.
73. Appleton MP, Kuehl TJ, Raebel MA, Adams HR, Knight AB, Gold WR. Magnesium sulfate versus phenytoin for seizure prophylaxis in pregnancy-induced hypertension. Am J Obstet Gynecol 1991; 165: 907-13.
74. Chien PFW, Khan KS, Arnott N. Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: an overview of the evidence from randomised trials. Br J Obstet Gynaecol 1996; 103: 1085-91.
75. Dommisse J. Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obstet Gynaecol 1990; 97: 104-9.
76. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth-weight infants? Pediatrics 1995; 95: 263-9.
77. FineSmith RB, Roche K, Yellin PB, et al. Effect of magnesium sulfate on the development of cystic periventricular leukomalacia in preterm infants. Am J Perinatol 1997; 14: 303-7.
78. Canterino JC, Verma UL, Visintainer PF, Figueroa R, Klein SA, Tejani NA. Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage. Obstet Gynecol 1999; 93: 396-402.
79. Grether JK, Hoogstrate J, Walsh-Greene E, Nelson KB. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am J Obstet Gynecol 2000; 183: 717-25.
80. Paneth N, Jetton J, Pinto-Martin J, Susser M. Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. The Neonatal Brain Hemorrhage Study Analysis Group. Pediatrics 1997; 99: e1.
81. Mittendorf R, Covert R, Boman J, Khoshnood B, Lee KS, Siegler M. Is tocolytic magnesium sulphate associated with increased total paediatric mortality? (Letter). Lancet 1997; 350: 1517-8.
82. Mittendorf R, Covert R, Elin R, Pryde PG, Khosnood B, Lee KS. Umbilical cord serum ionized magnesium level and total pediatric mortality. Obstet Gynecol 2001; 98: 75-8.
83. Ghoneim MM, Long JP. The interaction between magnesium and other neuromuscular blocking agents. Anesthesiology 1970; 32: 23-7.
84. Schulz-Stubner S, Wettmann G, Reyle-Hahn SM, Rossaint R. Magnesium as part of balanced general anaesthesia with propofol, remifentanil and mivacurium: a double-blind, randomized prospective study in 50 patients. Eur J Anaesthesiol 2001; 18: 723-9.
85. Thompson SW, Moscicki JC, DiFazio CA. The anesthetic contribution of magnesium sulfate and ritodrine hydrochloride in rats. Anesth Analg 1988; 67: 31-4.
86. Hollmann MW, Liu HT, Hoenemann CW, Liu WH, Durieux ME. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics. Anesth Analg 2001; 92: 1182-91.
87. Orser B, Smith D, Henderson S, Gelb A. Magnesium deficiency increases ketamine sensitivity in rats. Can J Anaesth 1997; 44: 883-90.
88. Liu HT, Hollmann MW, Liu WH, Hoenemann CW, Durieux ME. Modulation of NMDA receptor function by ketamine and magnesium: Part I. Anesth Analg 2001; 92: 1173-81.
89. Wilder-Smith OHG, Arendt-Nielsen L, Gäumann D, Tassonyi E, Rifat KR. Sensory changes and pain after abdominal hysterectomy: a comparison of anesthetic supplementation with fentanyl versus magnesium or ketamine. Anesth Analg 1998; 86: 95-101.
90. Zarauza R, Säez-Fernändez AN, Iribarren MJ, et al. A comparative study with oral nifedipine, intravenous nimodipine, and magnesium sulfate in postoperative analgesia. Anesth Analg 2000; 91: 938-43.
91. Wilder-Smith CH, Knöpfli R, Wilder-Smith OHG. Perioperative magnesium infusion and postoperative pain. Acta Anaesthesiol Scand 1997; 41: 1023-7.
92. Kroin JS, McCarthy RJ, Von Roenn N, Schwab B, Tuman KJ, Ivankovich AD. Magnesium sulfate potentiates morphine antinociception at the spinal level. Anesth Analg 2000; 90: 913-7.
93. Horner SM. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction. Circulation 1992; 86: 774-9.
94. Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ 1991; 303: 1499-503.
95. Gyamlani G, Parikh C, Kulkarni AG. Benefits of magnesium in acute myocardial infarction: timing is crucial. Am Heart J 2000; 139: e2.
96. Woods KL, Flether S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992; 339: 1553-8.
97. Woods KL, Flethcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1994; 343: 816-9.
98. ISIS-4 Fouth International Study of Infarct Survival Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-85.
99. Anonymous. Rationale and design of the magnesium in coronaries (MAGIC) study: a clinical trial to reevaluate the efficacy of early administration of magnesium in acute myocardial infarction. The MAGIC Steering Committee. Am Heart J 2000; 139: 10-4.
100. The Magnesium in Coronaries (MAGIC) Dial Investigators. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet 2002; 360: 1189-96.
101. Fatovich DM, Prentice DA, Dobb GJ. Magnesium in cardiac arrest (the magic trial). Resuscitation 1997; 35: 237-41.
102. Thel MC, Armstrong AL, McNulty SE, Califf RM, O'Connor CM. Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet 1997; 350: 1272-6.
103. Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA. Intravenous magnesium sulfate treatment for acute asthma in the emergency department: a systematic review of the literature. Ann Emerg Med 2000; 36: 181-90.
104. Alter HJ, Koepsell TD, Hilty WM. Intravenous magnesium as an adjuvant in acute bronchospasm: a meta-analysis. Ann Emerg Med 2000; 36: 191-7.
105. Rodrigo G, Rodrigo C, Burschtin O. Efficacy of magnesium sulfate in acute adult asthma: a meta-analysis of randomized trials. Am J Emerg Med 2000; 18: 216-21.
106. Devi PR, Kumar L, Singhi SC, Prasad R, Singh M. Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy. Indian Pediatr 1997; 34: 389-97.
107. Ciarallo L, Sauer AH, Shannon MW. Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial. J Pediatr 1996; 129: 809-14.
108. Mangat HS, D'Souza GA, Jacob MS. Nebulized magnesium sulphate versus nebulized salbutamol in acute bronchial asthma: a clinical trial. Eur Respir J 1998; 12: 341-4.
109. Skobeloff EM, Spivey WH, McNamara RM, Greenspon L. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA 1989; 262: 1210-3.
110. Bloch H, Silverman R, Mancherje N, Grant S, Jagminas L, Scharf SM. Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma. Chest 1995; 107: 1576-81.
111. Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med 2000; 154: 979-83.
112. Boulet LP, Becker A, Bérubé D, Beveridge R, Ernst P. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ 1999; 161(11 Suppl): S1-S61.
113. Attygalle D, Rodrigo N. Magnesium as first line therapy in the management of tetanus: a prospective study of 40 patients. Anaesthesia 2002; 57: 778-817.
114. Lozo E, Riecke K, Schwabe R, Vormann J, Stahlmann R. Synergistic effect of ofloxacin and magnesium deficiency on joint cartilage in immature rats. Antimicrob Agents Chemother 2002; 46: 1755-9.
115. Grolleau F, Gamelin L, Boisdron-Celle M, Lapied B, Pelhate M, Gamelin E. A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels. J Neurophysiol 2001; 85: 2293-7.